Caesar Rivise PC Receives Tier 1 Ranking in 2021 from Best Lawyers – U.S. News & World Report
Posted on Nov 5, 2020 in Firm News
We are pleased to announce that Best Lawyers – U.S. News & World Report has placed Caesar Rivise […]
Read MoreCaesar Rivise, PC Attorneys Recognized by “Best Lawyers in America”
Posted on Aug 24, 2020 in Firm News
Congratulations to our attorneys named to The Best Lawyers in America® latest ranking of peer-reviewed intellectual property attorneys: […]
Read MoreTen Caesar Rivise, PC Lawyers are 2020 SUPER LAWYERS
Posted on Jun 11, 2020 in Firm News
Ten Caesar Rivise attorneys have been selected to the 2020 Pennsylvania Super Lawyers list. Each year, no more […]
Read MoreThe Deepest Bench of the Best Lawyers
Posted on May 2, 2019 in Firm News
Caesar Rivise isn’t the largest law firm in Pennsylvania, but it does have more attorneys recognized in The […]
Read MoreCaesar Rivise PC Receives Tier 1 Ranking in 2019 from Best Lawyers – U.S. News & World Report
Posted on Nov 1, 2018 in News
We are pleased to announce that Best Lawyers – U.S. News & World Report has placed Caesar Rivise […]
Read MoreCaesar Rivise’s Diversity Shines Through in Victory for Generic Drug Manufacturers
Posted on Oct 18, 2018 in News
In an important victory for consumers, Judge Sheridan of the United States District Court for the District of […]
Read MoreCaesar Rivise Attorneys Named to 2017 Pennsylvania Super Lawyers
Posted on Jun 5, 2017 in News
Eleven Caesar Rivise attorneys have been selected to the 2017 Pennsylvania Super Lawyers list. Each year, no more than five percent of the lawyers in the state are selected through a combination of peer nominations, evaluations, and independent research.
Read More$1.9 Million Awarded to Defendants for Caesar Rivise Attorneys’ Fees in Exceptional Case
Posted on May 22, 2017 in News
In the case of Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., InvaGen Pharmaceuticals Inc., Civil Action No. 14-4042 (D.N.J.), the Honorable Stanley R. Chesler issued an Order on May 18, 2017 granting defendants’ motion to declare the case exceptional pursuant to 35 U.S.C. § 285, and ordering plaintiff to pay attorneys’ fees in the amount of $1,983,420.60 to defendants.
Read MoreCaesar Rivise Wins Motion For Attorneys’ Fees In Exceptional Case
Posted on Apr 18, 2017 in News
In the case of Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., InvaGen Pharmaceuticals Inc., Civil Action No. 14-042 (D.N.J.), the Honorable Stanley R. Chesler on April 12, 2017, granted defendants’ motion to have the case declared “exceptional” pursuant to 35 U.S.C. § 285 and awarded attorneys’ fees in an amount upwards of $2 million.
Read MoreRoxane Gets the Red Light from the Federal Circuit
Posted on Nov 17, 2016 in News
On November 17, 2016, in Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., Invagen Pharmaceuticals Inc., Appeal No. 16-1028, the Court of Appeals for the Federal Circuit sided with Defendants-Appellees Camber and Invagen, for the second time, in holding that the claim term “size 00 or less” meant “precisely size 00 or less” and excluded the elongated version size 00EL which Defendants were using. Robert S. Silver argued the appeal also represented Appellees.
Read More